11 funds
Funds
Risk Indicator
Net Asset Value
30/04/2019
30/04/2020
30/04/2020
30/04/2021
30/04/2021
30/04/2022
30/04/2022
30/04/2023
30/04/2023
30/04/2024
Equity strategies (11)
Equity strategiesCarmignac Investissement
FR0010148981
FCPGlobal marketSRI Fund Article 8
Risk Indicator
4/7
Net Asset Value
2046.5 €16/05/2024
12-month rolling performance
30/04/2019
30/04/2020
+ 3.4 %
30/04/2020
30/04/2021
+ 46.3 %
30/04/2021
30/04/2022
- 16.0 %
30/04/2022
30/04/2023
- 1.6 %
30/04/2023
30/04/2024
+ 28.5 %
Equity strategiesCarmignac Portfolio Investissement
LU1299311164
SICAVGlobal marketSRI Fund Article 8
Risk Indicator
4/7
Net Asset Value
183.0 €16/05/2024
12-month rolling performance
30/04/2019
30/04/2020
+ 3.9 %
30/04/2020
30/04/2021
+ 47.3 %
30/04/2021
30/04/2022
- 15.5 %
30/04/2022
30/04/2023
- 1.2 %
30/04/2023
30/04/2024
+ 28.8 %
Equity strategiesCarmignac Portfolio Grandchildren
LU1966631001
SICAVGlobal marketSRI Fund Article 9
Risk Indicator
5/7
Net Asset Value
191.9 €16/05/2024
12-month rolling performance
30/04/2019
30/04/2020
-
30/04/2020
30/04/2021
+ 31.1 %
30/04/2021
30/04/2022
- 0.1 %
30/04/2022
30/04/2023
+ 3.4 %
30/04/2023
30/04/2024
+ 21.1 %
Equity strategiesCarmignac Emergents
FR0010149302
FCPEmerging marketsSRI Fund Article 9
Risk Indicator
4/7
Net Asset Value
1270.8 €16/05/2024
12-month rolling performance
30/04/2019
30/04/2020
+ 0.3 %
30/04/2020
30/04/2021
+ 61.9 %
30/04/2021
30/04/2022
- 26.4 %
30/04/2022
30/04/2023
- 0.1 %
30/04/2023
30/04/2024
+ 15.3 %
Equity strategiesCarmignac Portfolio Emergents
LU1299303229
SICAVEmerging marketsSRI Fund Article 9
Risk Indicator
4/7
Net Asset Value
153.8 €16/05/2024
12-month rolling performance
30/04/2019
30/04/2020
+ 0.7 %
30/04/2020
30/04/2021
+ 60.9 %
30/04/2021
30/04/2022
- 26.3 %
30/04/2022
30/04/2023
+ 0.5 %
30/04/2023
30/04/2024
+ 15.0 %
Equity strategiesCarmignac Portfolio Emerging Discovery
LU0336083810
SICAVEmerging marketsSRI Fund Article 8
Risk Indicator
4/7
Net Asset Value
1933.3 €16/05/2024
12-month rolling performance
30/04/2019
30/04/2020
- 20.0 %
30/04/2020
30/04/2021
+ 33.3 %
30/04/2021
30/04/2022
- 0.4 %
30/04/2022
30/04/2023
- 9.6 %
30/04/2023
30/04/2024
+ 25.2 %
Equity strategiesCarmignac Portfolio China New Economy
LU2295992320
SICAVEmerging marketsSRI Fund Article 8
Risk Indicator
6/7
Net Asset Value
52.7 €16/05/2024
12-month rolling performance
30/04/2019
30/04/2020
-
30/04/2020
30/04/2021
-
30/04/2021
30/04/2022
- 49.6 %
30/04/2022
30/04/2023
+ 5.5 %
30/04/2023
30/04/2024
- 7.5 %
Equity strategiesCarmignac Portfolio Grande Europe
LU0099161993
SICAVEuropean marketSRI Fund Article 9
Risk Indicator
4/7
Net Asset Value
340.8 €16/05/2024
12-month rolling performance
30/04/2019
30/04/2020
+ 6.0 %
30/04/2020
30/04/2021
+ 34.0 %
30/04/2021
30/04/2022
- 4.5 %
30/04/2022
30/04/2023
+ 2.6 %
30/04/2023
30/04/2024
+ 12.5 %
Equity strategiesCarmignac Portfolio Climate Transition
LU0164455502
SICAVThematicESG Thematic Fund Article 8
Risk Indicator
5/7
Net Asset Value
318.5 €16/05/2024
12-month rolling performance
30/04/2019
30/04/2020
- 25.7 %
30/04/2020
30/04/2021
+ 45.0 %
30/04/2021
30/04/2022
- 5.5 %
30/04/2022
30/04/2023
+ 0.1 %
30/04/2023
30/04/2024
+ 2.7 %
Equity strategiesCarmignac Portfolio Human Xperience
LU2295992163
SICAVThematicESG Thematic Fund Article 9
Risk Indicator
4/7
Net Asset Value
125.9 €16/05/2024
12-month rolling performance
30/04/2019
30/04/2020
-
30/04/2020
30/04/2021
-
30/04/2021
30/04/2022
+ 1.6 %
30/04/2022
30/04/2023
- 2.6 %
30/04/2023
30/04/2024
+ 20.0 %
Equity strategiesCarmignac Portfolio Family Governed
LU1966630706
SICAVThematicESG Thematic Fund Article 8
Risk Indicator
4/7
Net Asset Value
175.0 €16/05/2024
12-month rolling performance
30/04/2019
30/04/2020
-
30/04/2020
30/04/2021
+ 37.6 %
30/04/2021
30/04/2022
- 1.4 %
30/04/2022
30/04/2023
+ 1.6 %
30/04/2023
30/04/2024
+ 18.9 %

Legal Information

The information presented above is not contractually binding and does not constitute investment advice. Reference to certain securities and financial instruments is for illustrative purposes to highlight stocks that are or have been included in the portfolios of funds in the Carmignac range. This is not intended to promote direct investment in those instruments, nor does it constitute investment advice. The Management Company is not subject to prohibition on trading in these instruments prior to issuing any communication. The portfolios of Carmignac funds may change without prior notice. Past performance is not a reliable indicator of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor), where applicable. Investors may lose some or all of their capital, as the capital in the UCI is not guaranteed. Access to the products and services presented herein may be restricted for some individuals or countries. Taxation depends on the situation of the individual. The risks, fees and recommended investment period for the UCI presented are detailed in the KIDs (Key Information Documents) and prospectuses available on this website. The KID must be made available to the subscriber prior to purchase. The reference to a ranking or prize, is no guarantee of the future results of the UCITS or the manager.